AFCo1 as nasal adjuvant of capsular polysaccharide from Neisseria meningitidis serogroup C induces systemic and mucosal immune responses

Scandinavian Journal of Infectious Diseases

Volumn 43, Issue 10, 2011, Pages 809-813

  Romeu, Belkis ^a   González, Elizabeth ^a   Zayas, Caridad ^a   Campo, Judith Del ^a   Acevedo, Reinaldo ^b   Cuello, Maribel ^a   Valdes, Yolanda ^a   Balboa, Julio ^a   Cabrera, Osmir ^a   Lastre, Miriam ^a   Pérez, Oliver ^a  

^a FINLAY INSTITUTE   (Cuba)

^b Molecular Biology Department   (Cuba)

Author keywords

Adjuvant; Immune responses; Nasal immunization; Polysaccharide

Indexed keywords

AFCO1; BACTERIAL POLYSACCHARIDE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2A; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN M; IMMUNOGLOBULIN SUBCLASS; IMMUNOLOGICAL ADJUVANT; MENINGOCOCCUS VACCINE; THYMUS INDEPENDENT ANTIGEN; UNCLASSIFIED DRUG;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY RESPONSE; ANTIBODY SPECIFICITY; ARTICLE; BACTERIAL STRAIN; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNIZATION; IMMUNOGENICITY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOSTIMULATION; MENINGOCOCCOSIS; MOUSE; MUCOSAL IMMUNITY; NEISSERIA MENINGITIDIS; NONHUMAN; SALIVA ANALYSIS; VAGINA SECRETION;

ADJUVANTS, IMMUNOLOGIC; ADMINISTRATION, INTRANASAL; ANIMALS; ANTIBODIES, BACTERIAL; ANTIGENS, BACTERIAL; BACTERIAL CAPSULES; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; INJECTIONS, INTRAMUSCULAR; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MICE; MICE, INBRED BALB C; NEISSERIA MENINGITIDIS, SEROGROUP C; PROTEOLIPIDS;

EID: 80052493229     PISSN: 00365548     EISSN: 16511980     Source Type: Journal    
DOI: 10.3109/00365548.2011.586648     Document Type: Article

References (15)

1. Brandtzaeg P, Pabst R. Let's go mucosal: communication on slippery ground. Trends Immunol 2004;25:570-7. (Pubitemid 39369732)
2. Harandi AM, Medaglini D. Mucosal adjuvants. Curr HIV Res 2010;8:1-6.
3. Chen W, Patel GB, Yan H, Zhang J. Recent advances in the development of novel mucosal adjuvants and antigen delivery systems. Hum Vaccin 2010;6:706-14.
4. Gonzalez-Fernandez A, Faro J, Fernandez C. Immune responses to polysaccharides: lessons from humans and mice. Vaccine 2008;26:292-300.
5. Harrison L, Mohan N, Kirkpatrick P. Meningococcal group A, C, Y, and W135 conjugate vaccine. Nature Rev 2010;9:429-30.
6. Perez O, Lastre M, Cabrera O, del Campo J, Bracho G, Cuello M, et al. New vaccines require potent adjuvants like AFPL1 and AFCo1. Scand J Immunol 2007;66:271-7. (Pubitemid 47063207)
7. del Campo J, Zayas C, Romeu B, Acevedo R, Gonz á lez E, Bracho G, et al. Mucosal immunization using proteolipo-some and cochleate structures from Neisseria meningitidis serogroup B induce mucosal and systemic responses. Methods 2009;49:301-8.
8. del Campo J, Lindqvist M, Cuello M, B ä ckstr ö m M, Cabrerra O, Persson J, et al. Intranasal immunization with a proteoliposome-derived cochleate containing recombinant gD protein confers protective immunity against genital herpes in mice. Vaccine 2010;28:1193-200.
9. Cuello M, Cabrera O, Martinez I, Del Campo J, Camaraza M, Sotolongo F, et al. New meningococcal C polysaccha-ride-tetanus toxoid conjugate physico-chemical and immu-nological characterization. Vaccine 2007;25:1798-805. (Pubitemid 46176328)
10. Zhang Q, Choo S, Everard J, Jennings R, Finn A. Mucosal immune responses to meningococcal group C conjugate and group A and C polysaccharide vaccines in adolescents. Infect Immun 2000;68:2692-7. (Pubitemid 30253843)
11. Cuello M, Cabrera O, del Campo J, Paraj ó n E, Sotolongo F, Camaraza M, et al. Mucosal immune responses to meningo-coccal C polysaccharide-protein conjugate in mice. Vaccine 2006;24:S72-3.
12. Fernandez C, Moller G. Serum antibody and cellular immune response in mice to dextran B512. Cell Immunol 1990;131: 41-51.
13. Rubinstein L, Garc í a-Ojeda P, Michon F, Jennings H, Stein K. Murine immune responses to Neisseria meningitidis group C capsular polysaccharide and a thymus-dependent toxoid conjugate vaccine. Infect Immun 1998;66:5450-6.
14. Stein K E. Thymus-independent and thymus-dependent responses to polysaccharide antigens. J Infect Dis 1992;165: S49-52.
15. Chu R, McCool T, Greenspan N, Schereiber J, Harding C. CpG oligodeoxynucleotides act as adjuvants for pneumococ-cal polysaccharide-protein conjugate vaccines and enhance antipolysaccharide immunoglobulin G2a (IgG2a) and IgG3 antibodies. Infect Immun 2000;68:1450-6. (Pubitemid 30108543)